Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
ixekizumab interleukin-17a biotech NA drugbank , DGIDB Senile Plaques[MeSHID:D058225]
Dental Plaque[MeSHID:D003773]
Psoriasis[MeSHID:D011565]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Arthritis
Psoriatic[MeSHID:D015535]		 7.96 approved,investigational antibody
ixekizumab interleukin-17a biotech NA drugbank , DGIDB Senile Plaques[MeSHID:D058225]
Dental Plaque[MeSHID:D003773]
Psoriasis[MeSHID:D011565]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Arthritis
Psoriatic[MeSHID:D015535]		 7.96 approved,investigational antibody,inhibitor
ixekizumab interleukin-17 NA Successful target TTD , DGIDB Senile Plaques[MeSHID:D058225]
Dental Plaque[MeSHID:D003773]
Psoriasis[MeSHID:D011565]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Arthritis
Psoriatic[MeSHID:D015535]		 7.96 approved inhibitor
ixekizumab interleukin-17 NA Successful target TTD , DGIDB Senile Plaques[MeSHID:D058225]
Dental Plaque[MeSHID:D003773]
Psoriasis[MeSHID:D011565]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Arthritis
Psoriatic[MeSHID:D015535]		 7.96 approved unknown
click here to return to the previous page